Previous 10 | Next 10 |
2024-01-28 08:00:00 ET As the calendar transitions from January to February, the upcoming week promises a flood of earnings reports from some of the world's largest companies by market capitalization. Among the noteworthy releases are anticipated updates from tech giants Microsoft ( ...
2024-01-27 07:54:00 ET Time in the market beats timing the market, hands-down. But how long should you own a stock? Famed investor Warren Buffett perhaps said it best: "When we own portions of outstanding businesses with outstanding managements, our favorite holding period is forever." ...
2024-01-26 15:00:55 ET More on SPDR S&P 500 ETF Trust SPY: Black Swan Hiding In Plain Sight 2024 Analyst Outlook: Jussi Askola On Being Selective With REITs, Dividend Investing SPY Is At Its Highest Risk Level (Technical Analysis) Investors withdraw capit...
2024-01-25 14:56:31 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...
Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded indication marks second disease for which Dupixent is approved in children this young, underscoring the commitment to bringing t...
TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in this year’s Regeneron Science Talent Search , the nation’s oldest and ...
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) traded at a new 52-week high today and are currently trading at $777.66. So far today, approximately 369.83k shares have been exchanged, as compared to an average 30-day volume of 371.41k shares. Regeneron Pharmaceuticals, Inc. discover...
2024-01-18 07:00:29 ET More on Argenx SE, Bayer, etc. Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) argenx: Back To Earth After 2 Clinical Tria...
2024-01-16 13:51:12 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks , and the sector in general, saw a widespread beat down over the past two years. Venture capital dried up, post-pandemic healthcare landscapes shifted, and regulatory clamp...
2024-01-16 10:50:09 ET Summary Investors are monitoring the S&P 500 stocks as the index starts the year with a pullback and uncertainty over interest rate cuts. Top-performing stocks include Juniper, Nvidia, Eli Lilly, Viatris, and Organon, while solar energy stocks and Boeing...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...